Aquarius Announces Debt Settlement Agreement

Rhea-AI Summary

Aquarius Surgical Technologies Inc. has announced a Debt Settlement Agreement to eliminate $196,000 in accrued debt by issuing 3,920,000 common shares. These shares will have a four-month hold period from issuance. This transaction involves a related party, Sinalta Investments Ltd., controlled by director N. Gary Van Nest. The company will utilize an exemption from formal valuation and minority shareholder approval due to financial hardship provisions. Aquarius specializes in minimally invasive medical laser systems for urology, enhancing patient care and operational efficiency.

Positive

• Settlement of $196,000 debt strengthens financial position.
• Issuance of common shares could improve liquidity.

Negative

• Debt settlement may dilute existing shareholders' equity.
• Related party transaction raises governance concerns.

MISSISSAUGA, ON / ACCESSWIRE / December 12, 2022 / Aquarius Surgical Technologies Inc. (CSE:ASTI), is pleased to announce that has entered into a Debt Settlement Agreement, to settle $196,000 of accrued debt by issuance of 3,920,000 common shares. The shares issued or will be subject to a four month hold period from the original issue date.

Related party transaction.

The Creditor under the Debt Settlement Agreement is Sinalta Investments Ltd., a company controlled by N. Gary Van Nest, a director of the Company, and accordingly this is a "related party transaction" as such term is defined by Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company will rely on the exemption from formal valuation and minority shareholder approval requirements set out in MI 61-101 as the financial hardship provisions of section 5.7(1)(e) of MI 61-101 are met.

About Aquarius Surgical Technologies Inc.

Aquarius Surgical Technologies is a provider of innovative, minimally invasive medical laser systems and consumables for multiple medical disciplines, principally in the field of urology. Solutions also include clinical education, service, support and maintenance. ASTI is focused on increasing the availability of services for patients, enhancing the quality of patient care, improving operationally efficiencies and reducing total operational costs.

For more information, please contact:

Gary Van Nest, CEO gary@sinaltainvestments.com
Lorne MacFarlance, CFO lornemac@eastlink.ca ; 902-496-7594

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Aquarius Surgical Technologies Inc.

View source version on accesswire.com:
https://www.accesswire.com/731469/Aquarius-Announces-Debt-Settlement-Agreement

FAQ

What is the Debt Settlement Agreement announced by AQQRF?

AQQRF has settled $196,000 of accrued debt by issuing 3,920,000 common shares.

Who is involved in the related party transaction for AQQRF?

The creditor is Sinalta Investments Ltd., controlled by N. Gary Van Nest, a director of AQQRF.

What is the significance of the four-month hold period for AQQRF's shares?

The shares issued under the Debt Settlement Agreement will be subject to a four-month hold period from the issuance date.

How does the Debt Settlement Agreement affect AQQRF's shareholders?

The issuance of new shares for debt settlement may dilute existing shareholders' equity.

What exemptions does AQQRF rely on for the related party transaction?

AQQRF is using exemptions from formal valuation and minority shareholder approval due to financial hardship provisions.